DMDD vs Bipolar Disorder: Key Differences for Parents

The biggest difference between disruptive mood dysregulation disorder (DMDD) and bipolar disorder is time. In DMDD, a child is irritable most of the day, nearly every day, for a year or longer, with frequent explosive outbursts. In bipolar disorder, mood changes come in episodes of mania, hypomania or depression that start, last days or weeks, and end. The two cannot be diagnosed together, and the difference matters because treatment, medication choices and the long-term outlook are not the same.

Before anything else

This comparison is part of our parent guide to teen and child bipolar disorder.

Chronic versus episodic: the core difference

Picture a mood timeline. For a child with DMDD, the line stays in the irritable range almost continuously, with sharp spikes several times a week when outbursts happen. It has looked like that for at least a year, with no break of three months or more, and it began before age 10.

For a young person with bipolar disorder, the line has distinct humps and dips: a stretch of days or weeks of mania or hypomania (energized, little need for sleep, fast talk, sometimes irritable), a stretch of depression, and often periods back near their usual self. The irritability, when present, is part of a package that changes together and is clearly different from baseline.

That is why the DSM-5 criteria for DMDD exclude any child who has had a distinct period of more than one day with the full symptoms of mania or hypomania. A single genuine episode moves the diagnosis toward bipolar disorder. Full detail on each condition is in What is DMDD? and Can a child have bipolar disorder?.

DMDD and bipolar disorder compared

The table summarizes DSM-5 criteria as reproduced by Baweja and colleagues (2016), NIMH’s DMDD and youth bipolar materials, and the episode durations described by the American Psychiatric Association.

The "cannot coexist" rule, explained

DSM-5 lists DMDD, bipolar disorder, oppositional defiant disorder and intermittent explosive disorder in a way that prevents double-counting the same irritability. DMDD cannot be diagnosed with bipolar disorder, ODD or IED. In practice:

• If a child has ever had a manic or hypomanic episode, the diagnosis is bipolar disorder, even if they also have chronic irritability.
• If a child meets criteria for both DMDD and ODD, only DMDD is given.
• DMDD can be diagnosed alongside ADHD, anxiety disorders and major depression.

This rule is one reason it matters how carefully the history is taken. A brief period of being "hyper" for an afternoon does not count as hypomania; a clinician will ask about specifics: how many days, how much sleep, what others noticed.

Does DMDD turn into bipolar disorder?

On current evidence, usually not. Follow-up research on children with severe mood dysregulation, the research category that led to DMDD, found that only 1 of 84 developed mania over about two years, compared with 58 of 93 children who had bipolar disorder. NIMH notes that youth with DMDD are at higher risk of later anxiety and depression.

That outlook changes how families and clinicians plan. For a child with DMDD, the focus is skills, family strategies and watching for anxiety or depression in the teen years. For a teen with bipolar disorder, the focus is preventing and treating mood episodes over the long term.

How treatment differs

DMDD

NIMH says psychotherapy is often tried first: cognitive behavioral therapy for the child and parent training for the family. There is no FDA-approved medication for DMDD itself. When symptoms stay severe, clinicians may use medicines off-label for specific parts of the picture, such as a stimulant when ADHD is present, an antidepressant for anxiety or depression, or an atypical antipsychotic for severe aggression.

Bipolar disorder

For bipolar disorder in young people, several medicines carry FDA approval. Some lithium products are approved for bipolar I disorder from age 7. Aripiprazole, risperidone, quetiapine, asenapine and cariprazine are approved for acute manic or mixed episodes from age 10, and lurasidone and the olanzapine-fluoxetine combination are approved for bipolar I depression in ages 10 to 17. Each has specific monitoring needs, covered in bipolar medication for teens. NIMH also lists family-focused therapy and cognitive behavioral approaches as evidence-based therapies for youth.

Because the medicines differ so much, getting the diagnosis right before starting a mood stabilizer or antipsychotic matters. It is also why a clinician may suggest a period of tracking mood and sleep before deciding.

Questions to ask yourself before the appointment

1. When did the irritability start? Before or after age 10?
2. Is your child irritable most days, or does it come in stretches of days or weeks?
3. Have there been periods when your child needed much less sleep yet had more energy than usual?
4. Has your child ever seemed unusually happy, silly or grandiose for several days in a row?
5. Are outbursts happening at school and with friends, or mainly at home?
6. Does anyone in the family have bipolar disorder, depression or another mood disorder?

Bring your answers, a few weeks of notes, and any school reports. They help a clinician decide quickly which questions to explore.

At Willow & Stone

Willow & Stone sees patients ages 10 and up, so a child younger than 10 is referred to a child psychiatry specialist. For older children and teens, our teen bipolar evaluation looks at the full history, including whether the pattern is chronic or episodic. The first visit is a 90-minute evaluation ($300), and follow-ups are $150. Insurance is accepted for Texas patients (coverage depends on the plan); outside Texas, visits are direct-pay with a superbill. Read more about bipolar disorder treatment at Willow & Stone.

Common Questions

Sources & Further Reading

• Baweja R et al. Disruptive mood dysregulation disorder: current insights. Neuropsychiatr Dis Treat, 2016
• NIMH: Disruptive Mood Dysregulation Disorder (NIH Pub. 23-MH-8119, 2023)
• NIMH: Bipolar Disorder in Children and Teens (NIH Pub. 23-MH-8081, 2023)
• American Psychiatric Association: Highlights of Changes from DSM-IV-TR to DSM-5 (2013)
• American Psychiatric Association: What Are Bipolar Disorders?
• FDA label: lithium carbonate (DailyMed, effective 2026-04-27)
• FDA label: VRAYLAR (cariprazine) (DailyMed, effective 2025-12-18)

This article is general education, not a diagnosis or advice for your situation. Do not start, stop, or change a medication without talking to the clinician who prescribes it; stopping a mood stabilizer suddenly can trigger relapse.